Andrew Warr
About Andrew Warr
Andrew Warr is an Upstream Process Development Senior Scientist currently employed at Adaptimmune Us in Abingdon, Oxfordshire. He has over a decade of experience in the field, having previously worked at Allergan Biologics Ltd. and Oxford Biomedica.
Current Role at Adaptimmune
Andrew Warr serves as the Upstream Process Development Senior Scientist at Adaptimmune. He has held this position since 2018, contributing to the company's advancements in cell therapy and immuno-oncology. His role involves overseeing the development and optimization of upstream processes, which are critical for the production of therapeutic products. Warr's expertise in this area supports the organization's mission to deliver innovative treatments for cancer.
Previous Experience in Upstream Process Development
Before joining Adaptimmune, Andrew Warr worked at several notable organizations in the biotechnology sector. He was employed as a Scientist in Upstream Process Development at Allergan Biologics Ltd. from 2011 to 2015. Following this, he served as an Upstream Process R&D Scientist at Oxford Biomedica for one year, from 2015 to 2016. His diverse experience in these roles has equipped him with a strong foundation in bioprocessing and development.
Education and Qualifications
Andrew Warr earned his Bachelor of Science degree in Biochemistry from the University of Leicester, completing his studies between 2007 and 2010. This educational background provided him with essential knowledge and skills in biochemical processes, which he has applied throughout his career in the biotechnology industry.
Career Timeline
Andrew Warr's career in the biotechnology field spans over a decade. He began his professional journey at Allergan Biologics Ltd. in 2011, where he worked for four years. Afterward, he transitioned to Oxford Biomedica for a year before joining Adaptimmune in 2017 as an Upstream Process Development Scientist. He was promoted to Senior Scientist in 2018, where he continues to work today.